Phacilitate Leaders World and World Stem Cell Summit 2019: editor’s picks

Written by RegMedNet

In this round-up, check out the talks not to miss at this year’s Phacilitate Leaders World (January 22-25, Miami, FL, USA), co-located with the World Stem Cell Summit.

Following the success of 2018, Phacilitate Leaders World and the World Stem Cell Summit will once again be co-located. This event in sunny Miami will bring over 2,000 attendees, 150 exhibitors and 300 speakers to discuss the cell therapy, stem cell and regenerative medicine ecosystem.

If you’re attending, make sure you stop by booth WSC 25 to meet the RegMedNet and Regenerative Medicine teams! We’re giving away goodie bags, containing a copy of the new The Glossary for Cell & Gene Therapy and Regenerative Medicine 2018, to all new members that sign up at the event. If you’re already a member, why not spin our wheel of fortune and win some delicious British treats!

In this post, Editor Freya Leask shares her highlights from the agenda.

Tuesday, January 22nd
Fireside chat

Bruce Levine (Center for Cellular Immunotherapies of the University of Pennsylvania and International Society for Cell and Gene Therapy) and Tom Whitehead (Co-Founder – Emily Whitehead Foundation)
Keeping pace with Advanced Therapies at FDA
Peter Marks, Director, Centre for Biologics Evaluation & Research (US Food and Drug Administration)
Wednesday, January 23rd
Are MSCs here to stay?
Arnold Caplan, (Case Western Reserve University), David Pearce (Sanford Health) and Joshua  M. Hare (Longeveron, LLC), chaired by Shane Shapiro (Mayo Clinic Center for Regenerative Medicine)
Strategic approaches towards cell and gene therapy product commercialisation
Wayne Froland (SwanBio Therapeutics), Amy Jennings (Casebia Therapeutics), Joy Cavagnaro (Access BIO) and Gary du Moulin (formerly Genzyme Biosurgery), chaired by Richard Snyder (Brammer Bio)
Thursday, January 24th
Status of cellular therapy and regenerative medicine in China
Peihua Lu (Lu Daopei Hospital)
Addressing CMC challenges to achieve the full potential of pluripotent stem cell therapies
Derek Hei (BlueRock Therapeutics)
Friday, January 25th
Can we learn to apply recent methodologies to generate IPSCs from cord blood?
Stephen Sullivan (GAiT)
Studying neuroinflammation in multiple sclerosis and Parkinson’s disease in space: an ISS project
Jeanne F. Loring (Scripps Research Institute)